EUIPO trademark

DEEPAFFEX

RegisteredEUIPOWord markClass 9Class 42

"DEEPAFFEX" is a word mark owned by NuraLogix Corporation, filed at the EUIPO on October 2, 2017. It is registered and covers classes 9 and 42.

Official EUIPO record
DEEPAFFEX
Word mark as filed with the EUIPO
Status
Registered
Filed
October 2, 2017
Registered
January 31, 2018
Expires
October 2, 2027
Application no.
017284886
Registration no.
017284886
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
2 classes
Ownership

Who owns DEEPAFFEX

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services DEEPAFFEX is filed for, grouped by Nice class.

  • Computer software for image processing; computer software for detection and processing of human affects, namely, physiological and psychological states; computer software for simulation of human affects, namely, physiological and psychological states; computer software for processing of medical images, namely, using machine learning techniques; computer software for processing of digital images for detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions, namely, for use in medical diagnostics, medical imaging, behavioural analysis, market research, market opinion polling, conducting business and market research surveys, collection of market research information, product research and development, marketing analysis, analysis of advertising response, and border, law enforcement, immigration, consular and security screening; security screening device featuring cameras for screening persons, namely, for detection of deception for use in border, law enforcement, immigration, consular and security screening of persons; device featuring cameras for detecting sentiment and emotional reactions to products, brands, and advertising of others, including to product display racks; computer software for enabling an on-line focus group for evaluating the goods and services of others; computer software for health care and medical diagnostics, namely, for performing internet-enabled remote health care and medical diagnostics

  • Providing software as a service (SaaS) for enabling others to access and use software for image processing; providing software as a service (SaaS) for enabling others to detect and process human affects, namely, physiological and psychological states; providing software as a service (SaaS) for enabling others to simulate human affects, namely, physiological and psychological states; providing software as a service (SaaS) for enabling others to access and use software for medical imaging, namely, using machine learning techniques; providing software as a service (SaaS) for enabling others to access and use software for processing digital images for detecting, measuring, evaluating and identifying emotion, sentiment, deception, emotional expressions, emotional reactions, facial expressions, facial expression signals, blood flow, physiological signals, and physiological expressions, namely, for use in medical diagnostics, medical imaging, behavioural analysis, market research, market opinion polling, conducting business and market research surveys, collection of market research information, product research and development, marketing analysis, analysis of advertising response, and border, law enforcement, immigration, consular and security screening; providing software as a service (SaaS) for enabling others to access and use software for enabling an on-line focus group for the goods and services of others; providing software as a service (SaaS) for enabling others to access and use software for health care and medical diagnostics, namely for performing internet-enabled remote medical diagnostics; computer software consulting; product design consulting services; technical consulting in the fields of image processing, medical diagnostics, medical imaging, behavioural analysis, market research, market opinion polling, conducting business and market research surveys, collection of market research information, product research and development, marketing analysis, analysis of advertising response, and border, law enforcement, immigration, consular and security screening

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/126 Section C.1.3
  2. Bulletin 2018/023 Section B.1
  3. Bulletin 2017/202 Section A.1
FAQ

About DEEPAFFEX

Who owns the trademark "DEEPAFFEX"?

The EUIPO trademark "DEEPAFFEX" (application 017284886) is owned by NuraLogix Corporation.

What is the status of "DEEPAFFEX"?

Its status at the EUIPO is: registered.

When was "DEEPAFFEX" registered?

It was registered on January 31, 2018 and is due to expire on October 2, 2027.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DEEPAFFEX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d4251-ce13-76fd-8dbc-c07c3eed0f4a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d4251-ce13-76fd-8dbc-c07c3eed0f4a",
  "object": "trademark",
  "mark_text": "DEEPAFFEX",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "017284886",
  "filing_date": "2017-10-02",
  "nice_classes": [
    9,
    42
  ],
  "owners": [
    {
      "name": "NuraLogix Corporation",
      "entity_id": "ent_019eb7e0-e2de-721d-87e9-965a657c53e1"
    }
  ]
}